nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—PRKD3—pancreas—duodenum cancer	0.0138	0.0138	CbGeAlD
Crizotinib—NEK9—digestive system—duodenum cancer	0.0134	0.0134	CbGeAlD
Crizotinib—MAPK7—pancreas—duodenum cancer	0.0127	0.0127	CbGeAlD
Crizotinib—PRKD1—digestive system—duodenum cancer	0.0122	0.0122	CbGeAlD
Crizotinib—MET—pancreas—duodenum cancer	0.0119	0.0119	CbGeAlD
Crizotinib—NEK9—endocrine gland—duodenum cancer	0.0111	0.0111	CbGeAlD
Crizotinib—ACVR1B—pancreas—duodenum cancer	0.011	0.011	CbGeAlD
Crizotinib—IKBKE—lymph node—duodenum cancer	0.0107	0.0107	CbGeAlD
Crizotinib—MET—digestive system—duodenum cancer	0.0102	0.0102	CbGeAlD
Crizotinib—PRKD1—endocrine gland—duodenum cancer	0.0101	0.0101	CbGeAlD
Crizotinib—SIK2—endocrine gland—duodenum cancer	0.00997	0.00997	CbGeAlD
Crizotinib—PRKD3—endocrine gland—duodenum cancer	0.00972	0.00972	CbGeAlD
Crizotinib—IGF1R—pancreas—duodenum cancer	0.00936	0.00936	CbGeAlD
Crizotinib—MAPK7—endocrine gland—duodenum cancer	0.00898	0.00898	CbGeAlD
Crizotinib—TXK—endocrine gland—duodenum cancer	0.00898	0.00898	CbGeAlD
Crizotinib—JAK3—digestive system—duodenum cancer	0.00897	0.00897	CbGeAlD
Crizotinib—DCLK1—digestive system—duodenum cancer	0.00891	0.00891	CbGeAlD
Crizotinib—STK4—digestive system—duodenum cancer	0.00881	0.00881	CbGeAlD
Crizotinib—MET—endocrine gland—duodenum cancer	0.00841	0.00841	CbGeAlD
Crizotinib—NUAK2—pancreas—duodenum cancer	0.00834	0.00834	CbGeAlD
Crizotinib—ALK—digestive system—duodenum cancer	0.00832	0.00832	CbGeAlD
Crizotinib—EPHA5—digestive system—duodenum cancer	0.00832	0.00832	CbGeAlD
Crizotinib—ACVR1—pancreas—duodenum cancer	0.00829	0.00829	CbGeAlD
Crizotinib—CDK7—endocrine gland—duodenum cancer	0.00813	0.00813	CbGeAlD
Crizotinib—STK35—pancreas—duodenum cancer	0.00812	0.00812	CbGeAlD
Crizotinib—IGF1R—digestive system—duodenum cancer	0.008	0.008	CbGeAlD
Crizotinib—ACVR1B—endocrine gland—duodenum cancer	0.00777	0.00777	CbGeAlD
Crizotinib—NEK9—lymph node—duodenum cancer	0.00767	0.00767	CbGeAlD
Crizotinib—AURKA—digestive system—duodenum cancer	0.00758	0.00758	CbGeAlD
Crizotinib—EPHA6—endocrine gland—duodenum cancer	0.00741	0.00741	CbGeAlD
Crizotinib—JAK3—endocrine gland—duodenum cancer	0.00741	0.00741	CbGeAlD
Crizotinib—DCLK1—endocrine gland—duodenum cancer	0.00737	0.00737	CbGeAlD
Crizotinib—PLK4—endocrine gland—duodenum cancer	0.00732	0.00732	CbGeAlD
Crizotinib—STK4—endocrine gland—duodenum cancer	0.00728	0.00728	CbGeAlD
Crizotinib—PRKD1—lymph node—duodenum cancer	0.00699	0.00699	CbGeAlD
Crizotinib—TBK1—pancreas—duodenum cancer	0.00695	0.00695	CbGeAlD
Crizotinib—PTK2—pancreas—duodenum cancer	0.00695	0.00695	CbGeAlD
Crizotinib—TYK2—pancreas—duodenum cancer	0.0069	0.0069	CbGeAlD
Crizotinib—LIMK1—lymph node—duodenum cancer	0.00689	0.00689	CbGeAlD
Crizotinib—ALK—endocrine gland—duodenum cancer	0.00688	0.00688	CbGeAlD
Crizotinib—FER—endocrine gland—duodenum cancer	0.00688	0.00688	CbGeAlD
Crizotinib—EPHA5—endocrine gland—duodenum cancer	0.00688	0.00688	CbGeAlD
Crizotinib—TYRO3—endocrine gland—duodenum cancer	0.00688	0.00688	CbGeAlD
Crizotinib—LYN—endocrine gland—duodenum cancer	0.00684	0.00684	CbGeAlD
Crizotinib—IRAK1—pancreas—duodenum cancer	0.00681	0.00681	CbGeAlD
Crizotinib—TNK1—endocrine gland—duodenum cancer	0.00681	0.00681	CbGeAlD
Crizotinib—BMPR1B—endocrine gland—duodenum cancer	0.00674	0.00674	CbGeAlD
Crizotinib—PRKD3—lymph node—duodenum cancer	0.00672	0.00672	CbGeAlD
Crizotinib—RPS6KB1—pancreas—duodenum cancer	0.00668	0.00668	CbGeAlD
Crizotinib—TNK2—endocrine gland—duodenum cancer	0.00661	0.00661	CbGeAlD
Crizotinib—IGF1R—endocrine gland—duodenum cancer	0.00661	0.00661	CbGeAlD
Crizotinib—DSTYK—lymph node—duodenum cancer	0.00656	0.00656	CbGeAlD
Crizotinib—MAP4K2—endocrine gland—duodenum cancer	0.00651	0.00651	CbGeAlD
Crizotinib—BLK—lymph node—duodenum cancer	0.00648	0.00648	CbGeAlD
Crizotinib—PTK2B—digestive system—duodenum cancer	0.00645	0.00645	CbGeAlD
Crizotinib—LTK—lymph node—duodenum cancer	0.00641	0.00641	CbGeAlD
Crizotinib—CASK—lymph node—duodenum cancer	0.00641	0.00641	CbGeAlD
Crizotinib—RIPK2—digestive system—duodenum cancer	0.00639	0.00639	CbGeAlD
Crizotinib—SLK—pancreas—duodenum cancer	0.00637	0.00637	CbGeAlD
Crizotinib—EPHB4—pancreas—duodenum cancer	0.00632	0.00632	CbGeAlD
Crizotinib—AURKA—endocrine gland—duodenum cancer	0.00626	0.00626	CbGeAlD
Crizotinib—TESK1—endocrine gland—duodenum cancer	0.00621	0.00621	CbGeAlD
Crizotinib—MAPK7—lymph node—duodenum cancer	0.00621	0.00621	CbGeAlD
Crizotinib—TXK—lymph node—duodenum cancer	0.00621	0.00621	CbGeAlD
Crizotinib—EPHA2—pancreas—duodenum cancer	0.0062	0.0062	CbGeAlD
Crizotinib—FES—lymph node—duodenum cancer	0.00615	0.00615	CbGeAlD
Crizotinib—MAP4K5—pancreas—duodenum cancer	0.00605	0.00605	CbGeAlD
Crizotinib—TEK—pancreas—duodenum cancer	0.00605	0.00605	CbGeAlD
Crizotinib—MERTK—endocrine gland—duodenum cancer	0.00604	0.00604	CbGeAlD
Crizotinib—PTK2—digestive system—duodenum cancer	0.00593	0.00593	CbGeAlD
Crizotinib—TBK1—digestive system—duodenum cancer	0.00593	0.00593	CbGeAlD
Crizotinib—LIMK2—endocrine gland—duodenum cancer	0.00591	0.00591	CbGeAlD
Crizotinib—TYK2—digestive system—duodenum cancer	0.00589	0.00589	CbGeAlD
Crizotinib—MAP3K12—endocrine gland—duodenum cancer	0.00585	0.00585	CbGeAlD
Crizotinib—ACVR1—endocrine gland—duodenum cancer	0.00585	0.00585	CbGeAlD
Crizotinib—FLT3—endocrine gland—duodenum cancer	0.00585	0.00585	CbGeAlD
Crizotinib—MET—lymph node—duodenum cancer	0.00581	0.00581	CbGeAlD
Crizotinib—STK35—endocrine gland—duodenum cancer	0.00573	0.00573	CbGeAlD
Crizotinib—RPS6KB1—digestive system—duodenum cancer	0.00571	0.00571	CbGeAlD
Crizotinib—FGR—digestive system—duodenum cancer	0.00567	0.00567	CbGeAlD
Crizotinib—CDK7—lymph node—duodenum cancer	0.00562	0.00562	CbGeAlD
Crizotinib—YES1—pancreas—duodenum cancer	0.00559	0.00559	CbGeAlD
Crizotinib—TAOK2—lymph node—duodenum cancer	0.00558	0.00558	CbGeAlD
Crizotinib—TAOK3—pancreas—duodenum cancer	0.00552	0.00552	CbGeAlD
Crizotinib—BMP2K—endocrine gland—duodenum cancer	0.00551	0.00551	CbGeAlD
Crizotinib—EPHB4—digestive system—duodenum cancer	0.0054	0.0054	CbGeAlD
Crizotinib—SRC—pancreas—duodenum cancer	0.00538	0.00538	CbGeAlD
Crizotinib—EPHA3—lymph node—duodenum cancer	0.00537	0.00537	CbGeAlD
Crizotinib—ACVR1B—lymph node—duodenum cancer	0.00537	0.00537	CbGeAlD
Crizotinib—JAK2—digestive system—duodenum cancer	0.00536	0.00536	CbGeAlD
Crizotinib—PTK2B—endocrine gland—duodenum cancer	0.00533	0.00533	CbGeAlD
Crizotinib—EPHA2—digestive system—duodenum cancer	0.0053	0.0053	CbGeAlD
Crizotinib—RIPK2—endocrine gland—duodenum cancer	0.00528	0.00528	CbGeAlD
Crizotinib—JAK3—lymph node—duodenum cancer	0.00512	0.00512	CbGeAlD
Crizotinib—EPHA4—endocrine gland—duodenum cancer	0.00511	0.00511	CbGeAlD
Crizotinib—DCLK1—lymph node—duodenum cancer	0.00509	0.00509	CbGeAlD
Crizotinib—PLK4—lymph node—duodenum cancer	0.00506	0.00506	CbGeAlD
Crizotinib—STK4—lymph node—duodenum cancer	0.00503	0.00503	CbGeAlD
Crizotinib—MAP3K2—endocrine gland—duodenum cancer	0.00501	0.00501	CbGeAlD
Crizotinib—TBK1—endocrine gland—duodenum cancer	0.0049	0.0049	CbGeAlD
Crizotinib—PTK2—endocrine gland—duodenum cancer	0.0049	0.0049	CbGeAlD
Crizotinib—TYK2—endocrine gland—duodenum cancer	0.00487	0.00487	CbGeAlD
Crizotinib—YES1—digestive system—duodenum cancer	0.00477	0.00477	CbGeAlD
Crizotinib—FER—lymph node—duodenum cancer	0.00475	0.00475	CbGeAlD
Crizotinib—ALK—lymph node—duodenum cancer	0.00475	0.00475	CbGeAlD
Crizotinib—STK10—digestive system—duodenum cancer	0.00473	0.00473	CbGeAlD
Crizotinib—RPS6KB1—endocrine gland—duodenum cancer	0.00472	0.00472	CbGeAlD
Crizotinib—TAOK3—digestive system—duodenum cancer	0.00471	0.00471	CbGeAlD
Crizotinib—TNK1—lymph node—duodenum cancer	0.0047	0.0047	CbGeAlD
Crizotinib—FGR—endocrine gland—duodenum cancer	0.00469	0.00469	CbGeAlD
Crizotinib—AXL—endocrine gland—duodenum cancer	0.00467	0.00467	CbGeAlD
Crizotinib—BMPR1B—lymph node—duodenum cancer	0.00466	0.00466	CbGeAlD
Crizotinib—MAP4K1—lymph node—duodenum cancer	0.00466	0.00466	CbGeAlD
Crizotinib—SRC—digestive system—duodenum cancer	0.00459	0.00459	CbGeAlD
Crizotinib—TNK2—lymph node—duodenum cancer	0.00457	0.00457	CbGeAlD
Crizotinib—IGF1R—lymph node—duodenum cancer	0.00457	0.00457	CbGeAlD
Crizotinib—MAP4K2—lymph node—duodenum cancer	0.0045	0.0045	CbGeAlD
Crizotinib—EPHB4—endocrine gland—duodenum cancer	0.00446	0.00446	CbGeAlD
Crizotinib—STK3—lymph node—duodenum cancer	0.00444	0.00444	CbGeAlD
Crizotinib—TIE1—lymph node—duodenum cancer	0.00444	0.00444	CbGeAlD
Crizotinib—JAK2—endocrine gland—duodenum cancer	0.00443	0.00443	CbGeAlD
Crizotinib—EPHA2—endocrine gland—duodenum cancer	0.00438	0.00438	CbGeAlD
Crizotinib—AURKA—lymph node—duodenum cancer	0.00433	0.00433	CbGeAlD
Crizotinib—TESK1—lymph node—duodenum cancer	0.00429	0.00429	CbGeAlD
Crizotinib—MAP3K3—endocrine gland—duodenum cancer	0.00427	0.00427	CbGeAlD
Crizotinib—TEK—endocrine gland—duodenum cancer	0.00427	0.00427	CbGeAlD
Crizotinib—MAP4K5—endocrine gland—duodenum cancer	0.00427	0.00427	CbGeAlD
Crizotinib—MERTK—lymph node—duodenum cancer	0.00418	0.00418	CbGeAlD
Crizotinib—CSF1R—digestive system—duodenum cancer	0.00412	0.00412	CbGeAlD
Crizotinib—LIMK2—lymph node—duodenum cancer	0.00409	0.00409	CbGeAlD
Crizotinib—NUAK2—lymph node—duodenum cancer	0.00407	0.00407	CbGeAlD
Crizotinib—MAP3K12—lymph node—duodenum cancer	0.00404	0.00404	CbGeAlD
Crizotinib—FLT3—lymph node—duodenum cancer	0.00404	0.00404	CbGeAlD
Crizotinib—ACVR1—lymph node—duodenum cancer	0.00404	0.00404	CbGeAlD
Crizotinib—STK35—lymph node—duodenum cancer	0.00396	0.00396	CbGeAlD
Crizotinib—YES1—endocrine gland—duodenum cancer	0.00394	0.00394	CbGeAlD
Crizotinib—STK10—endocrine gland—duodenum cancer	0.00391	0.00391	CbGeAlD
Crizotinib—TAOK3—endocrine gland—duodenum cancer	0.00389	0.00389	CbGeAlD
Crizotinib—ABL2—lymph node—duodenum cancer	0.00386	0.00386	CbGeAlD
Crizotinib—ABL1—pancreas—duodenum cancer	0.00382	0.00382	CbGeAlD
Crizotinib—BMP2K—lymph node—duodenum cancer	0.00381	0.00381	CbGeAlD
Crizotinib—SRC—endocrine gland—duodenum cancer	0.00379	0.00379	CbGeAlD
Crizotinib—PTK2B—lymph node—duodenum cancer	0.00368	0.00368	CbGeAlD
Crizotinib—RIPK2—lymph node—duodenum cancer	0.00365	0.00365	CbGeAlD
Crizotinib—EPHA4—lymph node—duodenum cancer	0.00353	0.00353	CbGeAlD
Crizotinib—MAP3K2—lymph node—duodenum cancer	0.00346	0.00346	CbGeAlD
Crizotinib—CSF1R—endocrine gland—duodenum cancer	0.00341	0.00341	CbGeAlD
Crizotinib—TBK1—lymph node—duodenum cancer	0.00339	0.00339	CbGeAlD
Crizotinib—PTK2—lymph node—duodenum cancer	0.00339	0.00339	CbGeAlD
Crizotinib—TYK2—lymph node—duodenum cancer	0.00337	0.00337	CbGeAlD
Crizotinib—IRAK1—lymph node—duodenum cancer	0.00332	0.00332	CbGeAlD
Crizotinib—RPS6KB1—lymph node—duodenum cancer	0.00326	0.00326	CbGeAlD
Crizotinib—ABL1—digestive system—duodenum cancer	0.00326	0.00326	CbGeAlD
Crizotinib—FGR—lymph node—duodenum cancer	0.00324	0.00324	CbGeAlD
Crizotinib—LCK—lymph node—duodenum cancer	0.00324	0.00324	CbGeAlD
Crizotinib—AXL—lymph node—duodenum cancer	0.00323	0.00323	CbGeAlD
Crizotinib—SLK—lymph node—duodenum cancer	0.00311	0.00311	CbGeAlD
Crizotinib—EPHB4—lymph node—duodenum cancer	0.00309	0.00309	CbGeAlD
Crizotinib—JAK2—lymph node—duodenum cancer	0.00306	0.00306	CbGeAlD
Crizotinib—EPHA2—lymph node—duodenum cancer	0.00303	0.00303	CbGeAlD
Crizotinib—MAP4K5—lymph node—duodenum cancer	0.00295	0.00295	CbGeAlD
Crizotinib—MAP3K3—lymph node—duodenum cancer	0.00295	0.00295	CbGeAlD
Crizotinib—TEK—lymph node—duodenum cancer	0.00295	0.00295	CbGeAlD
Crizotinib—EPHB6—lymph node—duodenum cancer	0.00282	0.00282	CbGeAlD
Crizotinib—YES1—lymph node—duodenum cancer	0.00273	0.00273	CbGeAlD
Crizotinib—STK10—lymph node—duodenum cancer	0.0027	0.0027	CbGeAlD
Crizotinib—ABL1—endocrine gland—duodenum cancer	0.00269	0.00269	CbGeAlD
Crizotinib—TAOK3—lymph node—duodenum cancer	0.00269	0.00269	CbGeAlD
Crizotinib—SRC—lymph node—duodenum cancer	0.00262	0.00262	CbGeAlD
Crizotinib—CSF1R—lymph node—duodenum cancer	0.00235	0.00235	CbGeAlD
Crizotinib—CYP3A5—pancreas—duodenum cancer	0.00223	0.00223	CbGeAlD
Crizotinib—CYP3A5—digestive system—duodenum cancer	0.00191	0.00191	CbGeAlD
Crizotinib—ABL1—lymph node—duodenum cancer	0.00186	0.00186	CbGeAlD
Crizotinib—CYP3A5—endocrine gland—duodenum cancer	0.00158	0.00158	CbGeAlD
Crizotinib—CYP3A4—digestive system—duodenum cancer	0.00143	0.00143	CbGeAlD
Crizotinib—ABCB1—pancreas—duodenum cancer	0.00119	0.00119	CbGeAlD
Crizotinib—CYP3A4—endocrine gland—duodenum cancer	0.00118	0.00118	CbGeAlD
Crizotinib—ABCB1—digestive system—duodenum cancer	0.00101	0.00101	CbGeAlD
Crizotinib—ABCB1—endocrine gland—duodenum cancer	0.000837	0.000837	CbGeAlD
Crizotinib—ABCB1—lymph node—duodenum cancer	0.000579	0.000579	CbGeAlD
